The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy - Editors' reply

Justine Davies; Sarah Linklater; Fiona Mitchell

doi:10.1016/S2213-8587(15)00007-8

The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy - Editors' reply

Justine Davies, Sarah Linklater, Fiona Mitchell

Applied Health Research

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	168-169
Number of pages	2
Journal	The Lancet Diabetes and Endocrinology
Volume	3
Issue number	3
Early online date	19 Feb 2015
DOIs	https://doi.org/10.1016/S2213-8587(15)00007-8
Publication status	Published - Mar 2015

Keywords

Diabetes Mellitus, Type 2/drug therapy
Humans
Hypoglycemic Agents/therapeutic use

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2213-8587(15)00007-8Licence: None: All rights reserved

https://doi.org/10.1016/S2213-8587(15)00007-8Licence: None: All rights reserved

Cite this

@article{bf5118f2f02a4a4d897dcd3a7ae05d73,

title = "The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy - Editors' reply",

keywords = "Diabetes Mellitus, Type 2/drug therapy, Humans, Hypoglycemic Agents/therapeutic use",

author = "Justine Davies and Sarah Linklater and Fiona Mitchell",

year = "2015",

month = mar,

doi = "10.1016/S2213-8587(15)00007-8",

language = "English",

volume = "3",

pages = "168--169",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy - Editors' reply

AU - Davies, Justine

AU - Linklater, Sarah

AU - Mitchell, Fiona

PY - 2015/3

Y1 - 2015/3

KW - Diabetes Mellitus, Type 2/drug therapy

KW - Humans

KW - Hypoglycemic Agents/therapeutic use

U2 - 10.1016/S2213-8587(15)00007-8

DO - 10.1016/S2213-8587(15)00007-8

M3 - Article

C2 - 25702246

SN - 2213-8587

VL - 3

SP - 168

EP - 169

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 3

ER -